Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$BNTX Q1 '25 Earnings Results & Recap
BioNTech's Q1 2025 posted a loss per share of ($1.96) better than a loss of ($2.57) expected. Revenue of $207 million was below the estimate of $228.96 million; the company's outlook anticipates stable vaccination rates but potential negative impacts from tariffs and public sentiment, while continuing to invest in oncology programs such as BNT327, which shows promising clinical data.1
2
